Key result
Bariatric surgery cuts all-cause mortality ~44% and lowers major cardiovascular events compared to control.
Why the study?
While bariatric surgery and modern medical therapies improve cardiometabolic risk factors in obesity, direct head-to-head comparisons assessing their impact on cardiovascular outcomes remain limited.
Does bariatric surgery compared to medical therapy or control reduce all-cause mortality and MACE in adults with obesity?
Meta-Analysis (n=1,800,000)
Does bariatric surgery compared to medical therapy or control reduce all-cause mortality and MACE in adults with obesity?
In a network meta-analysis of over 1.8 million adults with obesity, bariatric surgery outperformed medical therapy for reducing MACE, cardiovascular mortality, heart failure hospitalization, and myocardial infarction, though both strategies similarly reduced all-cause mortality.
Answers are grounded in this paper and cite their sources.
Bariatric surgery warrants consideration in obese adults; reinforces mortality benefit over controls in mixed randomized-observational meta-analysis.
Background Obesity is strongly associated with cardiovascular morbidity and mortality. While bariatric surgery and modern medical therapies improve cardiometabolic risk factors, direct head-to-head comparisons assessing their impact on cardiovascular outcomes remain limited. Purpose We performed a systematic review and network meta-analysis (NMA) to compare bariatric surgery and medical treatment on major clinical outcomes in adults with obesity. Methods A systematic literature search using PubMed and Scopus databases was conducted. Randomized and observational studies comparing bariatric surgery, medical treatment, or controls (patients that did not receive either medical treatment or undergone any bariatric surgery) were included in the analysis. The primary outcomes were all-cause mortality and MACE (as defined by each individual study), while cardiovascular mortality, heart failure hospitalization, myocardial infarction and stroke served as secondary outcomes. A frequentist random-effects NMA was conducted across three nodes with control patients as the reference comparator. Treatment effects were expressed as hazard ratios (HR) with 95% confidence intervals (CI) and treatments were ranked using p-scores. Results A total of 36 studies, comprising more than 1.8 million patients, were included in the meta-analysis. Compared with control, bariatric surgery significantly reduced all evaluated outcomes, including all-cause mortality (HR: 0.56, 95%CI: 0.49–0.64), MACE (HR: 0.54, 95%CI: 0.46–0.64), cardiovascular mortality (HR: 0.49, 95%CI: 0.36–0.67), heart failure hospitalization (HR: 0.48, 95%CI: 0.40–0.57), myocardial infarction (HR: 0.55, 95%CI: 0.47–0.64), and stroke (HR: 0.73, 95%CI: 0.63–0.83). Medical treatment was also associated with lower all-cause mortality (HR: 0.64, 95%CI 0.52–0.77), lower MACE (HR: 0.81, 95%CI: 0.66-0.99) and reduced heart failure hospitalization (HR: 0.79, 95%CI: 0.64–0.98), but showed no significant benefit for cardiovascular mortality, myocardial infarction, or stroke. In head-to-head network comparisons, bariatric surgery was significantly more effective than medical treatment in reducing MACE, cardiovascular mortality, heart failure hospitalization, and myocardial infarction. Notably, all-cause mortality—representing the most direct and clinically relevant endpoint—did not differ significantly between the two strategies, while no significant difference was observed for stroke. Bariatric surgery consistently ranked as the most effective intervention across all outcomes based on p-scores. Conclusion Bariatric surgery is associated with substantial reductions in major cardiovascular outcomes in adults with obesity and outperforms medical treatment for most endpoints in head-to-head comparisons. These findings support its central role in cardiovascular risk reduction, while highlighting the need for randomized trials directly comparing contemporary medical therapies with surgical approaches.
No takes yet. Share an insight, caveat, or question.
Roumeliotis et al. (2026) conducted a meta-analysis in Obesity (n=1,800,000). Bariatric surgery vs. Medical treatment and untreated controls was evaluated on All-cause mortality and MACE (as defined by each individual study) (HR 0.56, 95% CI 0.49-0.64). Bariatric surgery reduced all-cause mortality and major cardiovascular events versus control, and reduced major cardiovascular events more than medical therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: